8-K
Current Report
Calidi Biotherapeutics, Inc. Filed Acc 0001193125-23-032729
Material agreement · Regulation FD disclosure
- Item 1.01 Entry into a material definitive agreement
- Item 7.01 Regulation FD disclosure
From the SEC's structured data for this filing
Loading d442631d8k.htm…